Extracts or Active Components from Acorus gramineus Aiton for Cognitive Function Impairment: Preclinical Evidence and Possible Mechanisms

Abstract

Extracts or active components from Acorus gramineus Aiton (EAAGA) have been clinically used for cognition impairment more than hundreds of years and are still used in modern times in China and elsewhere worldwide. Previous studies reported that EAAGA improves cognition impairment in animal models. Here, we conducted a preclinical systematic review to assess the current evidence of EAAGA for cognition impairment. We searched 7 databases up until June 2019. Methodological quality for each included studies was accessed according to the CAMARADES 10-item checklist. The primary outcome measures were neurobehavioral function scores evaluated by the Morris water maze test, electrical Y-maze test, step-down test, radial eight-arm maze test, and step-through test. The secondary outcome measures were mechanisms of EAAGA for cognition function. Finally, 34 studies involving 1431 animals were identified. The quality score of studies range from 1 to 6, and the median was 3.32. Compared with controls, the results of the meta-analysis indicated EAAGA exerted a significant effect in decreasing the escape latency and error times and in increasing the length of time spent in the platform quadrant and the number of platform crossings representing learning ability and memory function (all P<0.01). The possible mechanisms of EAAGA are largely through anti-inflammatory, antioxidant, antiapoptosis activities, inhibition of neurotoxicity, regulating synaptic plasticity, protecting cerebrovascular, stimulating cholinergic system, and suppressing astrocyte activation. In conclusion, EAAGA exert potential neuroprotective effects in experimental cognition impairment, and EAAGA could be a candidate for cognition impairment treatment and further clinical trials.

The efficacy and safety of Chinese herbal medicine for mild cognitive impairment: a systematic review and meta-analysis of randomized placebo-controlled trials

“…Can enhance cognitive function across different experimental models of cognitive impairment. The potential underlying mechanisms include antioxidant, anti-apoptosis, anti-neurotoxicity, anti-cytotoxicity and anti-inflammatory effects, mitigation of Alzheimer’s disease-related pathology, synaptic protection, and the upregulation of neuronal cells through various signaling pathways ( Li et al, 2020 ; Liang et al, 2021 ; Zhang et al, 2023 ).…”

β-arrestin1 regulates astrocytic reactivity via Drp1-dependent mitochondrial fission: implications in postoperative delirium

“…This study provides insight into the mechanism of astrocytic inflammatory responses and mitochondrial functions regulated by β-arrestin-biased adrenergic receptors. Adrenergic systems are well-studied prototypes for heterotrimeric GPCRs that respond to diffusible hormones and neurotransmitters, which regulate both cognitive function and immune function, and dysregulation of adrenergic tone may potentiate neuroinflammation in neurological diseases [ 39 – 41 ]. Our previous study and other researches found that adrenergic receptors were implicated in the pathogenesis of perioperative neurocognitive disorder [ 10 , 41 , 42 ].…”

Therapeutic potential of traditional Chinese medicine on heat stroke

“…It has also been shown to help increase the expression of heat shock protein 70 and reduce the volume of cerebral infraction. Houpu ( Houpoea officinalis ) and Shichangpu ( Acorus gramineus ) have also been shown to have protective effects on blood pressure in HS rat by nose inhalation ( Li et al, 2020b ). Berberine, the important component of Huangbo ( Phellodendron amurense ), was proved to be effective on suppressing the expression of heat shock protein 70 and TNF-α and decreasing body temperature of HS( Jiang et al, 2017 ).…”